Jasper Therapeutics Announces European Union Orphan Drug Designation for Briquilimab as a Conditioning Treatment for Patients Prior to Receiving a Stem Cell Transplant
REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
Uniti Wholesale Expands Connectivity at Nine Data Centers, Bringing New Capacity to Key Markets